Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Medicure (MCUJF) Cash from Operations (2016 - 2025)

Medicure has reported Cash from Operations over the past 16 years, most recently at 22946.76 for Q4 2025.

  • For Q4 2025, Cash from Operations fell 98.61% year-over-year to 22946.76; the TTM value through Dec 2025 reached 423128.01, down 143.69%, while the annual FY2025 figure was 401568.32, 140.74% down from the prior year.
  • Cash from Operations for Q4 2025 was 22946.76 at Medicure, up from 377123.57 in the prior quarter.
  • Over five years, Cash from Operations peaked at 1721539.3 in Q4 2021 and troughed at 581053.9 in Q1 2022.
  • A 5-year average of 338721.14 and a median of 232455.68 in 2023 define the central range for Cash from Operations.
  • On a YoY basis, Cash from Operations climbed as much as 566.7% in 2025 and fell as far as 2298.67% in 2025.
  • Year by year, Cash from Operations stood at 1721539.3 in 2021, then tumbled by 78.65% to 367614.77 in 2022, then surged by 85.22% to 680914.43 in 2023, then skyrocketed by 142.75% to 1652895.67 in 2024, then crashed by 98.61% to 22946.76 in 2025.
  • Business Quant data shows Cash from Operations for MCUJF at 22946.76 in Q4 2025, 377123.57 in Q3 2025, and 526128.41 in Q2 2025.